Cognivia is pleased to announce an upcoming webinar focused on strategies for aligning with the FDA’s recent draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies.” This guidance marks a significant advancement towards enhancing inclusivity and generalizability in clinical trial evidence, ensuring that data accurately reflects real-world patient populations.
Webinar Highlights:
- Building a Coherent, Comprehensive Diversity Action Plan: Learn how to develop an integrated approach that aligns with FDA guidance, ensuring that diversity, equity, and inclusion (DE&I) are embedded in every stage of the clinical development lifecycle.
- Insights from Industry and Academic Leaders: Gain valuable perspectives from experts across various sectors, providing a well-rounded view of practical and impactful strategies.
- Mitigating Data Variability in Diverse Populations: Discover methods for managing the potential impact of increased data variability on trial outcomes and data interpretation, ensuring that diversity efforts enhance, rather than complicate, trial validity and applicability.
Expert Panel:
The webinar will feature an expert panel moderated by Sarah Thompson Schick, Counsel at Reed Smith LLP, who specializes in FDA regulatory compliance and clinical trial modernization, including diversity initiatives. Panelists include:
- Tinaya Gray, Global Head of Diversity in Clinical Trials at ICON plc, leading inclusive research strategies through the PACE program.
- Siân Ratcliffe Smethurst, SVP Head of Quantitative Sciences & Development Operations at Biogen, driving global clinical trial innovation and leading numerous regulatory initiatives.
- Dominique Demolle, CEO of Cognivia and a recognized leader in drug development.
- Ruby Madison Ford, from Tufts Center for the Study of Drug Development, offering insights on improving the representation of underrepresented groups in clinical research.
This panel will provide a comprehensive view of advancing diversity in clinical trials.
Event Details:
- Date: December 4th at 10 am EST
Don’t miss this opportunity to engage with leaders who are shaping the future of inclusive clinical trials.